Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Gross Profit: 2022-2024

Historic Gross Profit for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $177.4 million.

  • Arcutis Biotherapeutics' Gross Profit rose 130.65% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.0 million, marking a year-over-year increase of 130.22%. This contributed to the annual value of $177.4 million for FY2024, which is 224.82% up from last year.
  • Arcutis Biotherapeutics' Gross Profit amounted to $177.4 million in FY2024, which was up 224.82% from $54.6 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Gross Profit ranged from a high of $177.4 million in FY2024 and a low of $2.9 million during FY2022.
  • Moreover, its 3-year median value for Gross Profit was $54.6 million (2023), whereas its average is $78.3 million.
  • Data for Arcutis Biotherapeutics' Gross Profit shows a peak YoY surged of 1,762.86% (in 2023) over the last 5 years.
  • Arcutis Biotherapeutics' Gross Profit (Yearly) stood at $2.9 million in 2022, then soared by 1,762.86% to $54.6 million in 2023, then surged by 224.82% to $177.4 million in 2024.